apollo
logo
0Login
Introducing Our Latest Arrival!
Emecad 0.25mg Injection

Emecad 0.25mg Injection

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Cadila Pharmaceuticals Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

About Emecad 0.25mg Injection

Emecad 0.25mg Injection belongs to a class of drugs called antiemetics used to prevent nausea and vomiting during chemotherapy. Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth.

Emecad 0.25mg Injection contains Palonosetron which works by blocking the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting.

Emecad 0.25mg Injection will be administered by a healthcare professional; do not self-administer. In some cases, you may experience diarrhoea, constipation, dizziness or headache. Most of these side effects of Emecad 0.25mg Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Emecad 0.25mg Injection or any other medicines, please tell your doctor. Emecad 0.25mg Injection may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Emecad 0.25mg Injection. Drive only if you are alert as Emecad 0.25mg Injection may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.

Uses of Emecad 0.25mg Injection

Treatment of Nausea and vomiting

Medicinal Benefits

Emecad 0.25mg Injection contains Palonosetron which blocks the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting during chemotherapy.

Directions for Use

Emecad 0.25mg Injection will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Emecad 0.25mg Injection

  • Diarrhoea
  • Constipation
  • Dizziness
  • Headache

Drug Warnings

If you are allergic to Emecad 0.25mg Injection or any other medicines, please tell your doctor. Emecad 0.25mg Injection may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Emecad 0.25mg Injection. Drive only if you are alert as Emecad 0.25mg Injection may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.

Drug Interactions

Drug-Drug Interaction: Emecad 0.25mg Injection may interact with antidepressants (citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, escitalopram, duloxetine, venlafaxine), heart-related drugs or high blood pressure (quinidine, amiodarone, nicardipine), antibiotics (moxifloxacin, erythromycin), antiemetic (domperidone), antipsychotic drugs (thioridazine, quetiapine, chlorpromazine, haloperidol).

Drug-Food Interaction: No interactions found.

Drug-Disease Interaction: If you have blocked bowel, repeated constipation, heart problems or imbalance of potassium and magnesium in the blood, inform your doctor before taking Emecad 0.25mg Injection.

Drug-Drug Interactions Checker List

  • CITALOPRAM
  • FLUVOXAMINE
  • PAROXETINE
  • SERTRALINE
  • ESCITALOPRAM
  • DULOXETINE
  • VENLAFAXINE
  • QUINIDINE
  • AMIODARONE
  • NICARDIPINE
  • MOXIFLOXACIN
  • ERYTHROMYCIN
  • DOMPERIDONE
  • THIORIDAZINE
  • QUETIAPINE
  • CHLORPROMAZINE
  • HALOPERIDOL

Habit Forming

No

Diet & Lifestyle Advise

  • Eat a healthy diet and a low-fat diet, especially in small portions, as it will be easy for digestion. Avoid eating over-sweet food and include more salty food, especially if you have been vomiting.
  • Also, if you like to vomit at a specific time, avoid eating your favourite food at that particular time as your taste for that food may get turned off.
  • Drink any other liquid at least 30 minutes after eating food.
  • If the smell of food makes you feel sick (vomit), do not cook food as it may worsen your condition. Let someone else do the cooking or use prepared food from the freezer.

Disease/Condition Glossary

Nausea and vomiting: Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth. In short, nausea and vomiting are not diseases but are symptoms of many conditions like infections, motion sickness, an early stage of pregnancy, and gastroparesis (slow stomach emptying). There is a receptor located in our brain known as the chemoreceptor zone (CTZ) that controls vomiting.

bannner image

Alcohol

Caution

The interaction of alcohol with Emecad 0.25mg Injection is unknown. Please consult a doctor before consuming alcohol with Emecad 0.25mg Injection.

bannner image

Pregnancy

Consult your doctor

Emecad 0.25mg Injection is given to pregnant women only if the doctor thinks the benefits outweigh the risks. Please inform your doctor if you are pregnant.

bannner image

Breast Feeding

Consult your doctor

Please inform your doctor before taking Emecad 0.25mg Injection if you are breastfeeding. Emecad 0.25mg Injection is given to breastfeeding women only if the doctor thinks the benefits are greater than the risks.

bannner image

Driving

Caution

Emecad 0.25mg Injection may cause tiredness or dizziness in some people. Therefore, avoid driving or operating heavy machinery if you feel tired or dizzy after taking Emecad 0.25mg Injection.

bannner image

Liver

Safe if prescribed

Emecad 0.25mg Injection may be safe to use in patients with liver problems if prescribed by a doctor. However, if you have any concerns regarding this, please discuss them with your doctor.

bannner image

Kidney

Safe if prescribed

Emecad 0.25mg Injection may be safe to use in patients with kidney problems if prescribed by a doctor. However, if you have any concerns regarding this, please discuss them with your doctor.

bannner image

Children

Caution

Emecad 0.25mg Injection may be given to children above 1 month in doses as advised by a doctor based on the child's body weight.

Country of origin

India
Other Info - EM93760

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Emecad 0.25mg Injection is used to treat nausea and vomiting.
Emecad 0.25mg Injection contains Palonosetron which works by blocking the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting.
You are not recommended to take erythromycin with Emecad 0.25mg Injection as it may increase the risk of severe irregular heart rhythm. However, please consult your doctor before taking other medicines with Emecad 0.25mg Injection.
Emecad 0.25mg Injection may cause constipation as a side effect. It is not necessary for everyone taking Emecad 0.25mg Injection to experience this side effect. However, if the condition persists or worsens, please consult a doctor.
Emecad 0.25mg Injection should be used with caution in patients suffering from heart problems as it may worsen the condition. Therefore, inform your doctor if you have any heart problems before taking have Emecad 0.25mg Injection so that the dose may be adjusted appropriately.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.